Nov. 23 (Bloomberg) -- Canadian doctors should hold off on using a batch of GlaxoSmithKline Plc’s swine flu vaccine...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL INDUSTRY
The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.
Pharmaceutical Industry is part of Business Exchange, suggested by
Ken Rhines.
This topic contains
2,453 news
and
2,581 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
The law of nature shows a dependence of various species of living beings on each other which is primarily a survival...
Marvelle Sullivan, the head of corporate legal M&A at Novartis AG (NYSE:NVS), spoke at The Deal Economy 2010...
World leaders meet at the illustrious NGP Summit in Florida to face up to economic woes.
http://www.the-scientist.com/blog/display/56142/
Pfizer Inc. (NYSE:PFE) employees concerned about their jobs may have a better idea of where they stand.
Nov. 4 (Bloomberg) -- Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack...
Two weeks after Johnson & Johnson (NYSE:JNJ) reported mixed earnings, which tugged stocks downward, the world's...
The approval by U.S. antitrust regulators of Pfizer Inc.'s (NYSE:PFE) acquisition of Wyeth is an outlier of how merger...
Placebos are getting more "effective". It sounds absurd but many "clinical studies "in the world of...
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D.
The Indian generic market has been plagued with reports of Indian counterfeit medicines getting sold in important...
Sept. 25 (Bloomberg) -- GlaxoSmithKline Plc’s search outside its own laboratories for new drugs is getting more...
A "2" way approach to business The Cancer Health forecasts are very promising and are expected to grow at a...
The H1N1 virus has now become the dominant influenza virus around the globe, with high levels and an increase of...
Once a powerful profit-machine, big pharma is stumbling ,the threat of further government intervention, drying product...
My, how far CME has come in the age of technology! It seems like just yesterday that CME was in the infancy stage of...
When Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) bought Proteolix Inc. on Oct. 12, (The Deal Pipeline subscription...
An explicit indicator of the government intervention in the Corporate strategies of Indian companies is a headliner in...
78 percent of US interested in mobile healthcare solutions
SAN FRANCISCO, Calif., Oct. 20 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation, an emerging leader in the...
I am in the process of developing LogiPharma 2010, a conference for supply chain and logistics decision makers in the...
On Wednesday, Pfizer Inc. (NYSE:PFE) received approval from the FTC for its $68 billion acquisition of Wyeth.
The race to offer H1N1 flu vaccination is picking up pace. While global H1N1 vaccine manufacturers like Sanofi Pasteur,...
Amid rising flu concerns, three big drug companies have formed deals that give them rights to new vaccines.
Top Sources: Pharmaceutical Industry
- BusinessWeek
- srcomblog.wordpress.com
- New York Times
- bloomberg.com
- Health Beat
- Reuters
- The Atlantic Business Channel
- 247wallst.com
- online.wsj.com
- blogs.forbes.com
Tweets on this Topic












account